These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 11012438

  • 1. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S.
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [Abstract] [Full Text] [Related]

  • 2. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T.
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [Abstract] [Full Text] [Related]

  • 3. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined.
    Onishi H, Murakami T, Kim T, Hori M, Iannaccone R, Kuwabara M, Abe H, Nakata S, Osuga K, Tomoda K, Passariello R, Nakamura H.
    Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347
    [Abstract] [Full Text] [Related]

  • 4. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim MJ, Kim JH, Lim JS, Oh YT, Chung JJ, Choi JS, Lee WJ, Kim KW.
    J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
    [Abstract] [Full Text] [Related]

  • 5. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR, Elliott S.
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [Abstract] [Full Text] [Related]

  • 6. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ.
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [Abstract] [Full Text] [Related]

  • 7. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
    Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK.
    Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
    [Abstract] [Full Text] [Related]

  • 8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 9. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
    Tanimoto A, Wakabayashi G, Shinmoto H, Nakatsuka S, Okuda S, Kuribayashi S.
    J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
    [Abstract] [Full Text] [Related]

  • 10. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
    Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS.
    Korean J Radiol; 2003 Apr; 4(1):1-8. PubMed ID: 12679628
    [Abstract] [Full Text] [Related]

  • 11. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration.
    Hirokawa Y, Isoda H, Okada T, Arizono S, Shimada K, Yamamoto A, Shibata T, Togashi K.
    Invest Radiol; 2010 Mar; 45(3):158-64. PubMed ID: 20142748
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
    Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, Wyatt JI, Robinson PJ.
    Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
    [Abstract] [Full Text] [Related]

  • 13. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C, Gaffke G, Gretschel S, Rambow A, Jost D, Schlecht I, Schneider U, Schicke B, Hohenberger P, Gebauer B, Felix R.
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [Abstract] [Full Text] [Related]

  • 14. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography.
    Yukisawa S, Okugawa H, Masuya Y, Okabe S, Fukuda H, Yoshikawa M, Ebara M, Saisho H.
    Eur J Radiol; 2007 Feb; 61(2):279-89. PubMed ID: 17070663
    [Abstract] [Full Text] [Related]

  • 15. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT.
    Radiology; 2003 Sep; 228(3):719-26. PubMed ID: 12881583
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
    Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM.
    Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
    [Abstract] [Full Text] [Related]

  • 17. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, Wettergren A, Rasmussen A, Hillingsoe J, Kirkegaard P, Thomsen C.
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [Abstract] [Full Text] [Related]

  • 18. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK, Kim CS, Kwak HS, Lee JM.
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [Abstract] [Full Text] [Related]

  • 19. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC.
    Eur Radiol; 2006 Jun; 16(6):1337-45. PubMed ID: 16453115
    [Abstract] [Full Text] [Related]

  • 20. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO.
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.